IL6 and COVID-19: From the first days of the pandemic, serum concentrations of both anti-inflammatory (IL-10) and pro-inflammatory cytokines (IL-2, IL-6, TNF-α) were found to be increased in severe cases of COVID-19, compared with patients with moderate disease, implying that a cytokine storm is linked to disease pathogenesis [15].